Mixed-function oxidase (MFO) induction in the mouse liver results in a rapid and sustained centrilobular hypertrophy associated with a hyperplastic response. In many studies, the long-term sequela of prolonged exposure is an increased incidence of lesions considered to be adenomas. Studies have shown in aged control mice that the burden of adenomas usually consists of lesions with basophilic cytoplasic staining and a uniform population of hepatocyte nuclei. With long-term feeding of MFO inducers, there is an additional burden of lesions diagnosed as adenomas having a different histological appearance with increased eosinophilic cytoplasm and pleomorphic nuclei. The incidence of hepatocarcinomas usually is not modified by the increased incidence of eosinophilic adenomas. Studies into the behavior of the eosinophilic lesions show that the hepatocytes approximate in their behavior to normal and not neoplastic cells. It is suggested that these lesions should not be considered a carcinogenic response to the chemical.
INTRODUCTION
The mouse has been one of the species of choice for carcinogenicity bioassays for many years; however, there is continuing debate concerning the value of the mouse for the recognition of carcinogenic hazard and the estimation of risk. The particular debate centers upon the induction of hepatic neoplasia. From data derived from the U.S. National Toxicology Program (NTP) bioassay program, one of the most common sites for the induction of neoplasia is the mouse liver, without evidence of induced neoplasia in other organs in the mouse or in the rat (19) .
Many of the compounds producing this effect are nongenotoxic agents and are inducers of the mixed-function oxidase (MFO) group of enzymes. These compounds cause an increase in liver weight and, upon histological examination, centrilobular hypertrophy characterized by an increase in cytoplasmic volume, resulting from smooth endoplasmic reticulum (SER), hypertrophy, and increasing nuclear pleomorphism (14, 22) . These early changes may be accompanied by an increase in DNA synthesis (9) . This constellation of effects is observed in both the rat and mouse, whereas in humans, although there is metabolic evidence of induction, the histological sequelae are not observed. Long-term administration of these compounds to rats and mice shows different end results in that little evidence indicates a consistent neoplastic response in the rat.
In the mouse, but not the rat, chronic administration of such compounds results in an increased burden of lesions that, over many years, have been diagnosed as nodular hyperplasia, hepatoma, adenoma, or carcinoma. The diagnostic criteria for these lesions have been debated at least since 1968 following a World Health Organization meeting on liver cancer (5) , at which time a recommendation was made to drop the term hepatoma. Much work has shown that, using defined histological criteria (3, 22, 49, 50, 51 ) , malignant behavior, that is, invasion and metastasis, is associated with a group of lesions characteristically having very abnormal trabecular structures. It is of interest that this histological pattern is observed in hepatocarcinomas in other species. The remaining group of lesions have a more simplified structure, often with residual portal tracts and hepatic veins, which have been diagnosed as either nodular hyperplasia or adenoma. In this review, the histological features and biological behavior of the simple nodules seen in mice, following treatment with the nongenotoxic inducers of the MFO group of enzymes, will be discussed. I have reviewed all the sections of liver from the studies given as examples. The strain differences in the incidence of hepatic lesions will not be considered, as the histological characteristic of the lesions does not appear to be strain-specific (12, 18, 24) .
HISTORICAL BACKGROUND
In many of the early descriptions of focal nodular lesions induced in the mouse (1, 2) , the lesions were designated &dquo;hepatomas.&dquo; The &dquo;hepatomas&dquo; were derived from hepatic parenchymal cells and, while compressing the surrounding liver, neither invasion nor metastasis was seen. Similar lesions were induced by carbon tetrachloride (11) and O-aminoazotoluene (2) . Little or no information on the malignant behavior, that is, invasion and metastasis, of the lesions was given. Others expressed the view that many of the &dquo;hepatomas&dquo; were carcinomas (36, 42) . The diagnosis of carcinoma was made in the absence of the definitive biological evidence (invasion and metastasis) in a reasonable proportion of the cases. Subsequently, many studies with a wide range of chemicals, including pesticides, industrial chemicals, and ther-apeutic agents, have reported focal proliferative lesions (tumors) with varying designations-hyperplasia, hepatoma, adenoma, and hepatocarcinoma. A consistent feature of these studies, however, is the low incidence of invasion and metastasis seen when the lesions are grouped together as a single class. Takayama and his colleagues (44) (45) (46) , using nitroso-compounds, have clearly demonstrated by the presence of distant metastasis, that malignant neoplasm of the liver can be readily induced in the mouse.
Recognizing that only a low incidence of metastasis was associated with nodular lesions (&dquo;hepatomas&dquo;), Walker et al (50) attempted to make a correlation between the morphology of these lesions and their biological behavior. These authors designated 2 groups of lesions: the first, Type A (arbitrary designation), is difficult to distinguish in morphology and staining characteristics from the adjacent normal liver and is composed of regular arrangements of closely packed cells compressing the surrounding liver. The trabeculae are 1, or occasionally 2, cells thick. Normal mitoses are seen within these lesions. The second group, designated Type B (arbitrary designation), consists of nodules showing an irregular papillary pattern in which the orderly trabecular pattern is lost, with wide papillary forms or trabeculae many cells thick set in dilated sinusoidal beds. Hemorrhage and necrosis occur in the majority of these lesions. Associated with these lesions is an adenomatous pattern where the parenchymal cells appeared to form acini. Walker et al (50) found that metastasis was associated only with the Type B lesion. The range of lesions observed by Walker et al (50) was confirmed by Jones and Butler (22) . Gellatly (17) attempted to refine the distinctions made by Walker et al (50) and reported a comparable spectrum of lesions. Gellatly divided the nodular lesions into 3 classes, or types, and found that metastasis was only associated with 1 morphological entity, which, in many of its features, corresponded to the Type B lesion of Walker et al (50) . This observation has been amply confirmed by Vesselinovitch and his colleagues (23, 48) using a variety of compounds such as benzo(a)pyrene, benzidine, aflatoxin, diethylnitrosamine, and ethylnitrosourea; they showed that neoplasms having an abnormal trabecular pattern and diagnosed as carcinomas ( Fig. 1 ) metastasized to the lungs. They showed that the abnormal trabecular growth pattern was virtually exclusively associated with pulmonary metastasis and the rate of metastasis increased from 5% in mice dying at 50-60 wk to approximately 50% at 110 wk.
The current consensus opinion (41) is that the lesions with abnormal trabeculae are hepatocarcinomas; however, various problems remain, not the least of which is the variable metastatic rate. This may reflect differing samplings of the lung, but the indications are that the incidence of metastasis reported by Vesselinovitch and his coworkers and this author (unpublished observations) in lesions induced by genotoxic agents or controls is higher than that observed in histological carcinomas in mice treated with nongenotoxic agents (12, 29) . Furthermore, Malarkey et al (26) showed that the incidence of hepatocarcinomas declines following removal of the causative agent. These findings may suggest an overdiagnosis of carcinomas, based on histological criteria, or that a group of nongenotoxic compounds modify the behavior of &dquo;spontaneously&dquo; occurring malignant tumors arising in treated mice.
The published work developing the consensus opinion that the lesions with an abnormal trabacular pattern are carcinoma has led to the reevaluation of carcinogenicity studies undertaken by the National Cancer Institute bioassay program. The pressure to reevaluate these studies came from the concern expressed over the possible hazard and risk of many pesticides to humans. Two examples of this can be given. During the suspension/cancellation proceedings of Heptachlor and Chlordane, the administrative law judge (The Honorable H. L. Perlman) referred several questions of scientific fact to the National Academy of Sciences. These questions were considered by the Pesticide Information Review and Evaluation Committee (PIREC) (35) . The tissue slides from a number of studies were reviewed and the panel reported 2 groups of lesions: (a) carcinomas and (b) hyperplastic nodules. In comparison with the National Cancer Institute (NCI) reports (30, 31) , there was a considerable difference in the incidence of both carcinomas and hyperplastic nodules, although the overall incidence of lesions was similar (Table I) . I have reviewed the NCI studies on Chlordane and Hepatochlor and substantially agree with the PIREC summary of diagnoses but not the overall interpretation. (30, 31 ) and reviewed by the PIREC of the National Academy of Sciences (35) .
u The NCI reports lesion as adenoma.
* p < 0.05.
The second example concerns Dicofol, a chlorinated pesticide. The NCI bioassay report (33) on this compound demonstrated an increase in carcinomas (Table II) ; however, a subsequent review by the NTP, commissioned by the Carcinogen Assessment Group of the EPA, clearly showed that the incidence of carcinomas was not affected by treatment but that an increase of benign neoplasia was evident. The same study has been reviewed by myself, Dr. E. Smuckler, and Dr. S. Vesselinovitch, and we essentially agree with the NTP diagnoses. These examples clearly show that the increased burden of induced lesions is benign. Furthermore, the studies demonstrate that increasing the incidence of lesions (adenomas) that were considered to be a stage of progression to carcinoma did not, in these studies, increase the risk of the mice developing hepatocarcinoma.
LESIONS ASSOCIATED WITH MFO INDUCERS
Histological features of chronic administration of MFO inducers in both the rat and mouse are now well recognized. Chronic administration of compounds such as DDT (chlorophenothane), DDE (l,l-Dichloro-2,2-bis(pchlorophenyl)ethylene), Chlordane, Heptachlor, permethrin, piperonyl butoxide, and phenobarbital causes hypertrophy of the centrilobular hepatocytes showing a pronounced eosinophilic cytoplasm (6) . Associated with the cytoplasmic changes, the nuclei are usually large with bizarre shapes with multiple nucleoli and prominent chromatin (Fig. 2 ). The increase in cytoplasmic volume and eosinophilia is a consequence of the proliferation of SER (10) . The increase of SER has not been quantitatively assessed in mouse, but in the rat morphometric data have shown a 317% increase in membrane area in the centrilobular cells within 28 days whereas the periportal cells show a 176% increase in the same time (28) . After a matter of weeks of feeding MFO inducers, isolated necrotic parenchymal cells are evident, associated with a focal inflammatory reaction.
At the end of an 18-24-mo feeding period, or in aged controls, there is an increased burden of nodules in the liver. The preceding data show that the simple type of nodule shows a dose-related increase whereas the incidences of carcinomas are not significantly increased over control levels (Tables I and II ). In the controls, the nodules vary considerably in size and correspond to the Type A and Type B lesions described by Walker et al (50) . The simple Type A nodules are composed of a regular population of usually basophilic hepatocytes with a uniform population of nuclei (Fig. 3 ). The nodules arise as foci of basophilic hepatocytes scattered through the liver lobule (48) , and this type of lesion can be greatly increased after treatment with genotoxic carcinogens (23, 48, 49) .
In contrast to the lesions seen in controls or following treatment with genotoxic carcinogens, treatment with MFO inducers results in an increased burden of lesions having different characteristics from those already described. The lesions can vary considerably in size and can be up to 2 cm in diameter. Histologically, they have essentially the simple trabecular structure reported by Walker et al (50) but with the cytological characteristics of the centrilobular hypertrophic cells seen in the adjacent liver. The cells are large, irregular in shape, and eosinophilic. The nuclei show considerable pleomorphism with many bizarre forms ( Fig. 4) (6, 12, 13, 16, 22) . The nodules can show marked peripheral compression, but invasion and metastasis are not usually seen. It is of interest that at very high doses of piperonyl butoxide (43) , causing both acute and chronic liver injury, carcinomas are observed and that McClain (29) reported carcinomas induced by phenobarbital. Ultrastructural studies clearly show abundant SER in the eosinophilic nodules displacing the other cytoplasmic organelles (10) . Biochemical studies have shown a marked sustained increase in MFO enzyme activity in both surrounding host liver and the large eosinophilic nodules (9, 16, 24, 25) . Histochemical studies have shown an increase of aniline hydroxylase activity within hypertrophic liver and eosinophilic nodules (7) . More detailed studies in our laboratory (unpublished data) and that of Reubner et al (37) clearly show the heterogeneous population of both spontaneous and induced tumors. It is of interest that the basophilic lesions, in the presence of MFO inducers, do not show evidence of enzyme induction. The mechanism of the loss of response is not known but reflects either a change in the ability to metabolize the compound or that the foci lose the portal blood and are supplied by the hepatic artery.
The current diagnostic criteria suggested by the Society of Toxicologic Pathologists (STP) guidelines (41) consider that all nodules with compression of surrounding liver should be diagnosed as adenomas (benign neoplasia). This is in the absence of evidence of autonomy. The term nodular hyperplasia is reserved for lesions in which there is evidence of hepatic damage. However, in carcinogenicity studies, the animal is exposed to the chemical for the duration of the experiment, which will afford a continuing proliferative stimulus. Therefore, in my opinion, it is inappropriate to diagnose all nodular lesions, in the absence of carcinoma, as adenoma. The preferred convention, accepting the difficulty of recognizing benign neoplasia, is to diagnose nodules with preexisting structures (portal triads and central veins) as hyperplasia and those without such evidence as adenoma. This convention is common practice in other areas of diagnostic histopathology.
When reviewing the carcinogenicity studies of a number of nongenotoxic MFO inducers, the lesions may be diagnosed as either hepatocarcinomas and adenomas (STP terminology) or a combination of adenomas and nodular hyperplasia, my preferred diagnosis. The adenoma/hyperplasia can be classified, on their tinctorial characteristics in hematoxylin and eosin staining, into either basophilic lesions or eosinophilic lesions. The histological characteristics of these lesions have already been described. Inevitably, there is variation in the staining intensity of sections derived from different laboratories ; therefore, a combination of comparative cell size, cytoplasmic staining, and nuclear pleomorphism allows the classification of lesions. This type of analysis has been done by me in a number of studies, and the results, listed in Table III , have been submitted to the appropriate regulatory agency. Analysis of these data clearly show that, under the conditions of the study, carcinomas occur in the treated mice but the incidence is not significantly effected by treatment. Furthermore, the incidence of basophilic lesions, the putative precursor lesion of carcinoma, seen in both controls and treated mice is not modified. The increased burden of adenoma/hyperplasia is caused by an increase in eosinophilic lesions.
We have shown in a detailed study of phenobarbitalinduced lesions that the histogenesis of eosinophilic adenoma/hyperplasia is different from that of the basophilic lesions seen in either control mice or those treated with genotoxic compounds (12, 13) . The eosinophilic lesions develop from the centrilobular hypertrophy/hyperplasia, whereas the basophilic lesions arise from foci scattered throughout the lobule (12, 48) . In susceptible mouse strains, overt hepatocarcinomas are seen in control mice. This has been suggested as evidence of preinitiated cells in the liver that are promoted during the aging process (40) . In increasing the burden of adenoma/hyperplasia by the MFO inducers, it has been considered that this is also a promotional process affecting preinitiated hepatocytes. However, the data described earlier clearly demonstrate that the MFO inducers, when given alone, are not acting as promoters in carcinogenicity studies. A promoter would increase the background incidence of carcinomas and also increase the incidence of the putative precancerous lesions (basophilic foci and adenomas). Neither of these effects is observed. The MFO inducers increase the incidence of a lesion that has a different histogenesis and phenotype and has differing biological behavior from hepatocarcinomas in that the lesions are seldom associated with invasion and metastasis. Phenobarbital may delay or inhibit the development of adenomas and carcinomas in mice treated by diethylnitrosamine (DEN) (52) .
THE NATURE OF EOSINOPHILIC NODULES
From the preceding discussion, it is clear that, in susceptible species of mice, MFO inducers when fed for TABLE III.-Summary of hepatocellular carcinomas and simple nodules (adenomas/hyperplasia) in studies reviewed by the author. between 18 and 24 mo result in an increasing burden of benign eosinophilic nodules but not carcinomas. The incidence is dose-dependent, and in some instances males are more affected and in others females are more effected.
Although by current convention these lesions are diagnosed as adenoma (benign neoplasia) and are usually grouped with the basophilic lesions (adenoma), the putative precursor lesions for hepatocarcinoma, the question remains, Is this correct?
The definitive criterion for determining autonomous growth (neoplasia) is growth-independent of the administered compound (54) . Evidence of regression following cessation of treatment would suggest that the lesion is reactive and not neoplastic; however, no reasonably large-scale experiment has been published to unequivocally determine reversibility. Ito et al (21) treated mice with hexachlorocyclohexane for varying time periods and, upon withdrawal of the compound, allowed the an- (34) .
Abbreviations: BN = basophilic nodule; EN = eosinophilic nodule; HCC = hepatocellular carcinoma. imals to survive to 18 mo. Some evidence of reversal was obtained but little detailed description of the histology was given. In a small number of mice, Evans et al (13) showed that following 60 wk of treatment with phenobarbital followed by a period of 40 wk on normal diet the number of nodules was reduced. More recently, Malarkey et al (26) fed Chlordane to C3H mice and found that the incidence of lesions diagnosed as hepatocarcinomas was reduced when the mice were returned to normal diet. These authors suggested that Chlordane induced &dquo;dependent&dquo; tumors.
The in vitro growth of both eosinophilic nodules and carcinomas has been studied (34) . In these studies, clear differences were shown between eosinophilic nodules and carcinomas. The results of the experiments are shown in Table IV . In culture, the cells from eosinophilic nodules are similar to normal liver, and those derived from carcinomas have the growth characteristics of transformed cells. When transplanted into nude mice, the carcinomas from DEN-treated mice take readily with a short latent period, whereas the eosinophilic nodules failed to grow (4/8) or only grew after a prolonged period (4/8) . These studies suggest clear biological differences between eosinophilic nodules and induced carcinomas. It is clear that such experiments require repeating and expansion with much greater numbers plus comparison with unequivocal carcinoma induced by the nongenotoxic peroxisome proliferators. The molecular biology of mouse liver tumors has been studied extensively with varying results. Recently, the field has been reviewed in great detail by Maronpot et al (27) , showing that in control B6C3F, mice H-ras mutation at codon 61 is seen in a substantial number of tumors from control mice. This finding is repeatable in many laboratories, but the frequency is lower in other strains and does not correlate with the susceptibility to tumor formation. When induced by genotoxic agents, a similar or increased frequency of H-ras mutation at codon 61 is observed, although the exact ras mutation is somewhat compound-dependent. It has recently been shown (8) that high concentrations of DEN give a spectrum of mutation similar to that seen in control tumors; however, lower doses give rise to a mutation spectrum that is compounddependent. These results can be compared with studies undertaken on lesions resulting from MFO induction where no H-ras mutations were observed in phenobarbital-induced eosinophilic nodules (38, 39) . Fox et al (15) reported a greatly reduced incidence of mutation also following phenobarbital, although details of the histopathology were not given. A similar pattern of the lack of H-ras mutation is reported for Chlordane (26) and aroclor 1254 (39) . It is of interest that adenomas and carcinomas arising following chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment are reported as having a pattern of H-ras mutation similar to the controls (53) . Although TCDD is a potent inducer of MFO activity, the mechanism of this induction is different from those compounds discussed in this review (4, 20) . In summary, the current data on the H-ras mutation indicate that the lesions caused by MFO induction are different from adenomas/ carcinomas seen in both control mice and mice treated with genotoxic agents.
CONCLUSION
The weight of evidence clearly suggests that the lesions caused by the MFO inducers in mice and diagnosed by convention as adenomas are biologically different from tumors seen in controls or mice treated with genotoxic agents. The tumors resulting from the nongenotoxic peroxisome proliferators are not considered in this review, as the evidence suggests that they approximate more closely the pattern of genotoxic compounds in their effects upon the liver. The evidence of the lack of induced malignant neoplasia in the primary host, the histogenesis of the lesions, the in vitro and transplantation behavior, and the molecular biology all suggest that the lesions under consideration do not satisfy the basic criteria for neoplastic autonomous growth and more closely approximate to normal liver. The suggested pathways of development are outlined in Fig. 5 .
The difficulty in interpreting end-stage lesions of a bioassay is that there are no definitive criteria to distinguish autonomous benign lesions from reactive hyperplasia in the continued presence of the inducing agent (6). By convention, histological diagnosis, human or veterinary, depends on the association of a histological pattern with a known biological behavior. The histological diagnosis of adenoma based on the presence of a focal proliferative lesion compressing surrounding tissue is a convenience but gives no information of the autonomous nature of the growth. The continued proliferative stimulus is evidenced by the presence of cell necrosis with or without fibrosis FIG. 5.-Proposed pathogenesis of hepatic tumors in the mouse. The sequence of basophilic foci to carcinomas or directly arising carcinomas is seen in control mice and mice treated with genotoxic carcinomas. The sequence of eosinophilic hypertrophy to adenomas is seen following enzyme induction. and the presence of centrilobular hypertrophy and hyperplasia. However, in the absence of such overt observations there is little or no evidence to suggest the mechanism of the proliferative drive. However, such lack of information should not determine the positive diagnosis of neoplasia and the consequences derived from that diagnosis.
The detailed analysis of the in vitro growth characteristics of lesions induced by genotoxic agents and nongenotoxins, with an understanding of the role of oncogene mutation and oncoprotein expression in developing neoplasia, may elucidate many problems of the biological behavior of this disparate collection of lesions. However, in a sense, such data are derivative of the behavior of the tumor in the primary host and do not demonstrate autonomy in the primary host. To demonstrate that a lesion is autonomous and is not reactive, it is necessary to demonstrate that the &dquo;neoplasm&dquo; continues to proliferate in the absence of the causative agent. This requires a reversibility study in which lesions, &dquo;neoplasms,&dquo; are induced by continuous treatment with a compound. Following the production of the lesion, the compound is withdrawn and the fate of the lesion determined. If the lesions regress in the absence of the causative agent, the definition of autonomous growth has not been satisfied, indicating that the lesions are reactive and not neoplastic. Combined with the reversibility data, detailed mechanistic studies, outlined earlier, on the same tissue, would indicate the biological parameters important for establishing autonomous growth.
Presently all lesions diagnosed as adenomas/carcinomas are considered together for establishing the carcinogenic hazard of a compound. The results of the preceding studies suggest that this approach is not valid. The lesions related to MFO inducers have different biological characteristics from both control and lesions induced by genotoxic agents. The evidence suggests that the &dquo;ade-nomas&dquo; may not be neoplasia. If this is the case, the anomalous findings in the mouse will be resolved and such compounds should not be classified as carcinogens. ACKNOWLEDGMENTS I thank the Agrocultural Chemical Group, EM.C, Piperonyl Butoxide Task Force II, M.G.K. Corporation, and Rohm & Haas Company for allowing me to publish my reviews of the studies and Dr. Paul C. Rumsby for many helpful suggestions.
